Cantitate/Preț
Produs

Stereochemical Aspects of Drug Action and Disposition: Handbook of Experimental Pharmacology, cartea 153

Editat de Michel F. Eichelbaum, Bernard Testa, Andrew Somogyi
en Limba Engleză Paperback – 21 oct 2012

Din seria Handbook of Experimental Pharmacology

Preț: 37824 lei

Preț vechi: 39815 lei
-5% Nou

Puncte Express: 567

Preț estimativ în valută:
7239 7537$ 6118£

Carte tipărită la comandă

Livrare economică 10-24 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783642625756
ISBN-10: 3642625754
Pagini: 472
Ilustrații: XXV, 442 p.
Dimensiuni: 155 x 235 x 25 mm
Greutate: 0.65 kg
Ediția:Softcover reprint of the original 1st ed. 2003
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Handbook of Experimental Pharmacology

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

Chemical Aspects.- 1 Recent Developments in Asymmetric Organic Synthesis: Principles and Examples.- 2 Stereoselective Separations: Recent Advances in Capillary Electrophoresis and High-Performance Liquid Chromatography.- 3 Stereochemical Issues in Bioactive Natural Products.- 4 Drug Racemization and Its Significance in Pharmaceutical Research.- 5 Physical Properties and Crystal Structures of Chiral Drugs.- Experimental Pharmacology.- 6 Chiral Recognition in Biochemical Pharmacology: An Overview.- 7 Enantioselectivity in Drug-Receptor Interactions.- 8 Mechanisms of Stereoselective Binding to Functional Proteins.- 9 Stereoselective Drug-Channel Interactions.- 10 Stereoselective Bioactivation and Bioinactivation — Toxicological Aspects.- Drug Absorption, Distribution, Metabolism, Elimination.- 11 Intestinal Drug Transport: Stereochemical Aspects.- 12 Enantioselective Plasma and Tissue Binding.- 13 Stereoselective Drug Metabolism and Drug Interactions.- 14 Metabolic Chiral Inversion of 2-Arylpropionic Acids.- 15 Stereoselective Renal Elimination.- Implications for Drug Development and Therapy.- 16 Regulatory Requirements for the Development of Chirally Active Drugs.- 17 Improving Clinical Risk/Benefit Through Stereochemistry.